Restoration Robotics, Inc. (HAIR) EPS Estimated At $-0.17

Analysts expect Restoration Robotics, Inc. (NASDAQ:HAIR) to report $-0.17 EPS on March, 4.They anticipate $0.05 EPS change or 41.67 % from last quarter’s $-0.12 EPS. After having $-0.20 EPS previously, Restoration Robotics, Inc.’s analysts see -15.00 % EPS growth. The stock increased 2.22% or $0.02 during the last trading session, reaching $0.92. About 1.17 million shares traded or 140.83% up from the average. Restoration Robotics, Inc. (NASDAQ:HAIR) has declined 81.18% since March 3, 2018 and is downtrending. It has underperformed by 81.18% the S&P500.

Restoration Robotics, Inc., a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company has market cap of $37.42 million. It offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. It currently has negative earnings.

More notable recent Restoration Robotics, Inc. (NASDAQ:HAIR) news were published by: Globenewswire.com which released: “Restoration Robotics® Announces Preliminary Unaudited Fourth Quarter 2018 Revenue – GlobeNewswire” on January 07, 2019, also Nasdaq.com with their article: “Week Ahead In Pharmaceuticals: 6 Stocks To Watch (EOLS, AVRO, SGMO…) – Nasdaq” published on February 01, 2019, Nasdaq.com published: “Should Boston Beer Have Investors So Optimistic? – Nasdaq” on February 26, 2019. More interesting news about Restoration Robotics, Inc. (NASDAQ:HAIR) were released by: Nasdaq.com and their article: “Can Soap & Cleaning Materials Industry Players Balance Costs & Growth? – Nasdaq” published on February 21, 2019 as well as Globenewswire.com‘s news article titled: “Restoration Robotics® Secures ISO 13485:2016 Certification Nasdaq:HAIR – GlobeNewswire” with publication date: January 02, 2019.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.